INMD•INMD•| Metric | Beat/Miss | Actual | Consensus Estimate |
|---|---|---|---|
| Q2 Revenue | Beat | $95.59 mln | $93.03 mln (5 Analysts) |
| Q2 Net Income | Miss | $17.06 mln | $20.23 mln (4 Analysts) |
| Q2 Income from Operations | Miss | $12.26 mln | $18.11 mln (5 Analysts) |
| Q2 Pretax Profit | Miss | $19.69 mln | $23.10 mln (3 Analysts) |
| Q2 Operating Expenses | $59.26 mln |
Israel medical device maker's Q2 revenue was flat yr/yr but beat analyst expectations
Q2 net income, operating income, and pretax profit all missed analyst estimates
Company completed $87.8 mln share buyback during the quarter
Steady U.S. demand - Co said U.S. capital equipment business remained stable, reflecting steady customer demand
Asia growth - Revenue from Asia reached a quarterly record, reflecting continued strength across key markets in the region
Higher costs and expenses - Co said lower margins were due to higher cost of goods sold, product mix, sales team restructuring, increased marketing and sales investments, and higher general and administrative expenses
